CD11c‐positive cells from brain, spleen, lung, and liver exhibit site‐specific immune phenotypes and plastically adapt to new environments
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
The brain's immune privilege has been also attributed to the lack of dendritic cells (DC) within its parenchyma and the adjacent meninges, an assumption, which implies maintenance of antigens rather than their presentation in lymphoid organs. Using mice transcribing the green fluorescent protein under the promoter of the DC marker CD11c (itgax), we identified a juxtavascular population of cells expressing this DC marker and demonstrated their origin from bone marrow and local microglia. We now phenotypically compared this population with CD11c/CD45 double‐positive cells from lung, liver, and spleen in healthy mice using seven‐color flow cytometry. We identified unique, site‐specific expression patterns of F4/80, CD80, CD86, CX3CR1, CCR2, FLT3, CD103, and MHC‐II. Furthermore, we observed the two known CD45‐positive populations (CD45 high and CD45 int) in the brain, whereas liver, lung, and spleen exhibited a homogeneous CD45 high population. CD11c‐positive microglia lacked MHC‐II expression and CD45 high/CD11c‐positive cells from the brain have a lower percentage of MHC‐II‐positive cells. To test whether phenotypical differences are fixed by origin or specifically develop due to environmental factors, we transplanted brain and spleen mononuclear cells on organotypic slice cultures from brain (OHSC) and spleen (OSSC). We demonstrate that adaption and ramification of MHC‐II‐positive splenocytes is paralleled by down‐regulation of MHC‐II, whereas brain‐derived mononuclear cells neither ramified nor up‐regulated MHC‐II in OSSCs. Thus, brain‐derived mononuclear cells maintain their MHC‐II‐negative phenotype within the environment of an immune organ. Intraparenchymal CD11c‐positive cells share immunophenotypical characteristics of DCs from other organs but remain unique for their low MHC‐II expression. GLIA 2015;63:611–625
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of microglial neurotoxicity by the fractalkine receptor
Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1715 · Cited by 1,531 · cited 2×
“…microglia contain a higher percentage of cells expressing CX3CR1 and F4/80, which are known as markers for resident macrophages and microglia (Cardona et al., 2006; Carson et al., 1998; Harrison et al., 1998; Jung et al., 2000; Lewis et al., 2011; Niess, 2005; Prinz et al., 2011; Wlodarczyk…”
BackgroundMicroglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways
Kierdorf, K., Erny, D., Goldmann, T., Sander, V., Schulz, C., Perdiguero, E. G., Wieghofer, P., Heinrich, A., Riemke, P., Hölscher, C., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3318 · Cited by 1,457
Self-citationMicroglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions
Mildner, A., Schmidt, H., Nitsche, M., Merkler, D., Hanisch, U.-K., Mack, M., Heikenwalder, M., Brück, W., Priller, J., & Prinz, M. (2007) · Nature Neuroscience · doi:10.1038/nn2015 · Cited by 1,089
Self-citationMicroglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain
Alliot, F., Godin, I., & Pessac, B. (1999) · Developmental Brain Research · doi:10.1016/s0165-3806(99)00113-3 · Cited by 884 · cited 1×
“…are commonly considered as microglia (Carson et al., 1998; Sedgwick et al., 1991), which originate from yolk sac-derived macrophage progenitors and populate the brain parenchyma during the prenatal 620 Volume 63, No. 4 development (Alliot et al., 1999; Ginhoux et al., 2010; Vinet et al., 2012).”
BackgroundDendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis
Greter, M., Heppner, F. L., Lemos, M. P., Odermatt, B. M., Goebels, N., Laufer, T., Noelle, R. J., & Becher, B. (2005) · Nature Medicine · doi:10.1038/nm1197 · Cited by 862 · cited 5×
“In contrast, macrophages are frequently characterized by their expression of CD11b and F4/80, although they are CD11c negative (Bulloch et al., 2008; Greter et al., 2005; Ji et al., 2013; Jung et al., 2002; McMahon et al., 2005).”
BackgroundInfluentialEpitope spreading initiates in the CNS in two mouse models of multiple sclerosis
McMahon, E. J., Bailey, S. L., Castenada, C. V., Waldner, H., & Miller, S. D. (2005) · Nature Medicine · doi:10.1038/nm1202 · Cited by 694 · cited 9×
“In contrast, macrophages are frequently characterized by their expression of CD11b and F4/80, although they are CD11c negative (Bulloch et al., 2008; Greter et al., 2005; Ji et al., 2013; Jung et al., 2002; McMahon et al., 2005).”
BackgroundInfluentialHeterogeneity of CNS myeloid cells and their roles in neurodegeneration
Prinz, M., Priller, J., Sisodia, S. S., & Ransohoff, R. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2923 · Cited by 674
Neuroprotective function for ramified microglia in hippocampal excitotoxicity
Vinet, J., van Weering, H. R., Heinrich, A., Kälin, R. E., Wegner, A., Brouwer, N., Heppner, F. L., van Rooijen, N., Boddeke, H. W., & Biber, K. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-27 · Cited by 274
Self-citationTickets to the brain: Role of CCR2 and CX3CR1 in myeloid cell entry in the CNS
Prinz, M., & Priller, J. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.015 · Cited by 172
Wlodarczyk, A., Løbner, M., Cédile, O., & Owens, T. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-57 · Cited by 149 · cited 3×
“…contain a higher percentage of cells expressing CX3CR1 and F4/80, which are known as markers for resident macrophages and microglia (Cardona et al., 2006; Carson et al., 1998; Harrison et al., 1998; Jung et al., 2000; Lewis et al., 2011; Niess, 2005; Prinz et al., 2011; Wlodarczyk et al., 2014).”
BackgroundResultCan DCs be distinguished from macrophages by molecular signatures?
Hume, D. A., Mabbott, N., Raza, S., & Freeman, T. C. (2013) · Nature Immunology · doi:10.1038/ni.2516 · Cited by 69
Reply to: "Can DCs be distinguished from macrophages by molecular signatures?"
Randolph, G., & Merad, M. (2013) · Nature Immunology · doi:10.1038/ni.2517 · Cited by 13 · cited 8×
“However, due to the recent debate on the nature of DCs (Geissmann et al., 2010; Hume, 2008; Randolph and Merad, 2013), the question arose whether this parenchymal population can be addressed as DCs, implying the ability to stimulate na€ıve T-cells and to transfer antigens into lymphoid organs, or…”
BackgroundInfluential
Cited by
Neuroinflammation: Microglia and T Cells Get Ready to Tango
Schetters, S. T. T., Gomez-Nicola, D., Garcia-Vallejo, J. J., & Van Kooyk, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01905 · Cited by 382
Kamphuis, W., Kooijman, L., Schetters, S., Orre, M., & Hol, E. M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.07.007 · Cited by 209
Protective Microglial Subset in Development, Aging, and Disease: Lessons From Transcriptomic Studies
Benmamar-Badel, A., Owens, T., & Wlodarczyk, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00430 · Cited by 124
Coles, J. A., Myburgh, E., Brewer, J. M., & McMenamin, P. G. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.05.002 · Cited by 123
CNS-resident classical DCs play a critical role in CNS autoimmune disease
Giles, D. A., Duncker, P. C., Wilkinson, N. M., Washnock-Schmid, J. M., & Segal, B. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci123708 · Cited by 99
Metadata
- Authors
- Immig, K., Gericke, M., Menzel, F., Merz, F., Krueger, M., Schiefenhövel, F., Lösche, A., Jäger, K., Hanisch, U., Biber, K., & Bechmann, I.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2014-12-03
- Volume
- 63
- Issue
- 4
- Pages
- 611-625
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2102572577
- Cited by
- 45
- References
- 12
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.